Importance Disparities persist in testing and treatment for hepatitis C virus (HCV), leaving
socially marginalized populations less likely to benefit from curative treatment. Linkage …

Background Point-of-care hepatitis C virus (HCV) RNA testing can facilitate single-visit
diagnosis and treatment. This study evaluated a single-visit test and treat intervention …

Summary Background Although treatment for Hepatitis C Virus (HCV) is effective, individuals
face access barriers. The utility of mobile health clinics (MHC), effective mechanisms for …

Despite new Hepatitis C virus (HCV) therapeutic advances, challenges remain for HCV
testing and linking patients to care. A point-of-care (POC) HCV antibody testing strategy was …

Background The inequitable prevalence of hepatitis C (HCV) in the homeless is a clinical
and public health concern. Prior research estimates, at least one-quarter of homeless …

Importance In the US, the prevalence of hepatitis C virus (HCV) is 1.8% among people who
are Black and 0.8% among people who are not Black. Mortality rates due to HCV are …

Objectives: The care cascade, a method for tracking population-level progression from
diagnosis to cure, is an important tool in addressing and monitoring the hepatitis C virus …

Background Despite high burden of Hepatitis C (HCV) among people who inject drugs,
significant barriers to care persist. The aim of this study was to evaluate the provision of …

Background Despite the goal set by WHO to eliminate hepatitis C virus (HCV) as a public
health threat, uptake of HCV testing and treatment remains low. To achieve this target …

Background People who inject drugs have high rates of hepatitis C (HCV) and yet many
remain undiagnosed and untreated. HCV treatment guidelines and elimination strategies …